ViaNautis

Series-A
vianautis.com Biotech & Healthcare Cambridge, United Kingdom
Total Funding $25M
Latest Round Undisclosed Series-A
Last Announced Oct 31, 2024
Investors 10 Backers
Decision Makers 6 Available

About ViaNautis

ViaNautis is transforming cell and gene therapy with polyNaut®, a versatile, non-viral, targeted polymer-based nanovesicles delivery system that enables precise

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Cambridge, United Kingdom
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website vianautis.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @ViaNautisBio (45 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $25,000,000 · Series-A

    startupintros.com

Investors & Backers

10
4BIO Capital
Abcam
BGF Ventures
Cystic Fibrosis Foundation
Eli Lilly
Meltwind Advisory
O2h Ventures
Origin Capital
SCI Ventures
UCB Ventures

Funding History

2 Rounds
Series-A equity · Oct 31, 2024
Series-A equity · Nov 13, 2023

Founders & Leadership

7

Adi Hoess

CEO

Work email & phone locked Unlock →

Denis Cecchin

Founder

Work email & phone locked Unlock →

Francesca Crawford

Founder

Work email & phone locked Unlock →

Giuseppe Battaglia

Founder

Work email & phone locked Unlock →

Ray Jupp

Chief Scientific Officer

Work email & phone locked Unlock →

Sam Smart

Chief Financial Officer

Work email & phone locked Unlock →

Samuel Barker

Chief Business Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts